Trying each day to B strong, B faithful, B Happy, and B elieve
About Brayden and his fight.
One week after Brayden’s second birthday,
Brayden tolerated his treatments as well as expected for a two year old child. He was amazing and a real trooper. The 6 weeks of radiation therapy finished on
Unexpectedly, Brayden’s
Brayden’s March MRI showed regrowth again. This time, his doctors decided to send us to
Since his gamma procedure, life has been good. Home, family and friends are truly the best medicine for Brayden! We had a scare after his October scan. His oncologist thought Brayden may have had some regrowth again at the base of his brain. After sending his scans to be reviewed by the doctors in
*Update*
Unfortunately the October scan was showing early indication of tumor regrowth. Brayden had a 5th brain surgery on 1/9/06. This was the toughest yet. The tumor had wrapped around his brain stem. It had grown from a tiny size of a pencil point to golf ball size in a short two months. Amazingly, Dr. Coulon was able to remove the tumor at 100%. It took four weeks in the hospital for Brayden to regain muscle control and ability to walk. Brayden being the child that he is has once again defied the odds and recovered in amazing time. His doctors keep saying "He is a miracle". The decision was made to give Brayden another round of conformal radiation. He completed 25 treatments (4500 units) on March 9, 2006. He is once again back to being Brayden. He began preschool again and is happy to be home playing with his brothers. Thank You Jesus!!!
Brayden recurred in August '06 with a spinal tumor. The tumor was removed and he was home a week later. He then received 30 treatments of rads to the spine. By October '06 Brayden's MRI scan revealed 4 tumors in the brain. Brayden enjoyed life, familiy and many buddies right until his sunset on 12/29/06 @ 10:15 a.m. He went peacfully. The day before he left us, he made his first communion and confirmation. He spent the evening at Chuckie Cheese with several of his buddies. He finished the evening at the movies and then went home and built a train track with his aunt. He was B right until the end. "Thank You Jesus"
Alternate Names: None
Ependymomas arise from cells lining the passageways in the brain that produce and store the cerebrospinal fluid or CSF. (CSF is a fluid that bathes the brain and spinal cord.) These tumors are classified as either supratentorial (in the top part of the head) or infratentorial (in the back of the head). In children, the majority of ependymomas occur as infratentorial tumors arising in or around the fluid-filled fourth ventricle.
Ependymomas represent approximately six percent of brain tumors in children. The majority of patients are diagnosed before the age of five years.
The location of the tumor determines the clinical features and symptoms. Patients present with the common symptoms of increased pressure on the brain--nausea, vomiting, and headache. Patients with infratentorial tumors may also have unsteady gait, problems with coordination, and neck pain or stiffness resulting from irritation of the upper cervical nerves by the tumor. Supratentorial tumors usually present with complaints of headaches, weakness in the arms and legs, and sometimes, visual abnormalities (blurred vision). Very few ependymomas spread to other parts of the brain or to the spinal cord before they are diagnosed.
Surgery and radiation therapy are the main treatment approaches. Aggressive surgical resection is strongly recommended prior to radiation therapy in order to ensure the best possible long term outcome.
The dose and the "field" of radiation is dependent on the location of the tumor and the specific features of the tumor cells (histology). Chemotherapy generally has not proved beneficial in previous clinical studies, but may be benecial in a limited setting prior to more surgery or if there is tumor recurrence.
If there is residual tumor, newer chemotherapeutic agents are being used after surgery, with the goal of shrinking the tumor before planned radiation therapy. Radiation oncologists are now using focal radiation techniques after surgery with excellent long term results. Another approach that is being studied is to consider repeated surgery in patients who still have tumor remaining after surgery and radiation therapy. The best survival rates are obtained in patients who have no visible tumor after surgery.General Information About Childhood Ependymoma
Childhood ependymoma is a disease in which malignant (cancer) cells form in the tissues of the brain and spinal cord.
The brain controls vital functions such as memory and learning, the senses (hearing, sight, smell, taste, and touch), and emotion. The spinal cord is made up of bundles of nerve fibers that connect the brain with nerves in most parts of the body.
About 1 in 11 childhood brain tumors are ependymomas. Although cancer is rare in children, brain tumors are the most common type of childhood cancer other than leukemia and lymphoma.
This summary refers to the treatment of primary brain tumors (tumors that begin in the brain). Treatment of metastatic brain tumors, which are tumors formed by cancer cells that begin in other parts of the body and spread to the brain, is not discussed in this summary.
There are many different types of brain tumors. Brain tumors can occur in both children and adults; however, treatment for children may be different than treatment for adults. Refer to the following PDQ summaries for more information:
The cause of most childhood brain tumors is unknown.
The symptoms of childhood ependymoma vary and often depend on the child’s age and where the tumor is located.
These symptoms may be caused by childhood ependymoma or other conditions. A doctor should be consulted if any of the following problems occur:
Tests that examine the brain and spinal cord are used to detect (find) childhood ependymoma.
The following tests and procedures may be used:
Childhood ependymoma is diagnosed and removed in surgery.
If a brain tumor is suspected, a biopsy is done by removing part of the skull and using a needle to remove a sample of the brain tissue. A pathologist views the tissue under a microscope to look for cancer cells. If cancer cells are found, the doctor will remove as much tumor as safely possible during the same surgery.
Certain factors affect prognosis (chance of recovery).
The prognosis (chance of recovery) depends on:
| Key Points for This Section |
|
After childhood ependymoma has been removed, tests are done to find out if there is tumor remaining.
The extent or spread of cancer is usually described as stages. For childhood ependymoma, tumors are described by grade and by where they are located in the central nervous system (brain and spinal cord). The grade of the tumor refers to how abnormal the cancer cells look under a microscope and how quickly the tumor is likely to grow and spread. It is important to know the grade of the tumor and if there were any cancer cells remaining after surgery in order to plan treatment. The following tests and procedures may be used:
There are three ways that cancer spreads in the body.
The three ways that cancer spreads in the body are:
When cancer cells break away from the primary (original) tumor and travel through the lymph or blood to other places in the body, another (secondary) tumor may form. This process is called metastasis. The secondary (metastatic) tumor is the same type of cancer as the primary tumor. For example, if breast cancer spreads to the bones, the cancer cells in the bones are actually breast cancer cells. The disease is metastatic breast cancer, not bone cancer.
Recurrent childhood ependymoma is a tumor that has recurred (come back) after it has been treated. Childhood ependymoma commonly recurs, usually at the original cancer site. The tumor may come back as long as 15 years or more after initial treatment.
There are different types of treatment for children with ependymoma.
Different types of treatment are available for children with ependymoma. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.
Because cancer in children is rare, taking part in a clinical trial should be considered. Some clinical trials are open only to patients who have not started treatment.
Children with ependymoma should have their treatment planned by a team of doctors with expertise in treating childhood brain tumors.
Your child’s treatment will be overseen by a pediatric oncologist, a doctor who specializes in treating children with cancer. The pediatric oncologist may refer you to other pediatric doctors who have experience and expertise in treating children with brain tumors and who specialize in certain areas of medicine. These may include the following specialists:
Some cancer treatments cause side effects that continue or appear years after cancer treatment has ended. These are called late effects. Late effects of cancer treatment may include physical problems; changes in mood, feelings, thinking, learning or memory; and having second cancers (new types of cancer). Some late effects may be treated or controlled. It is important to talk with your child's doctors about the possible late effects caused by some treatments. Refer to the PDQLate Effects of Treatment for Childhood Cancer for more information. summary on
Three types of standard treatment are used:
Surgery is used to diagnose and treat childhood ependymoma as described in the General Information section of this summary.
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells. There are two types of radiation therapy. External radiation therapy uses a machine outside the body to send radiation toward the cancer. Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer. The way the radiation therapy is given depends on the type and stage of the cancer being treated.
Certain ways of giving radiation therapy can help keep radiation away from healthy tissue:
Radiation therapy to the brain can affect growth and development in young children and is not standard treatment for children younger than 3 years. For this reason, conformal radiation therapy that limits damage to healthy brain tissue is being studied in infants and children with ependymoma.
Damage to the brain in young children treated for ependymoma is not always due to the effects of radiation therapy. For example, when hydrocephalus (abnormalfluid in the brain) is found at diagnosis, it is linked with lower intelligence test scores following surgery and before radiation therapy. buildup of
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the spinal column, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.
New types of treatment are being tested in clinical trials.
Information about clinical trials is available from the NCI Web site.
Patients may want to think about taking part in a clinical trial.
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's clinical trials database.
Follow-up tests may be needed.
Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests. This is sometimes called re-staging.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
<!----------------------->
|